Top compounds associated with response to ADGRF2


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib gCSI pan-cancer AAC -0.032 0.6
mRNA Rapamycin gCSI pan-cancer AAC -0.028 0.6
mRNA Crizotinib gCSI pan-cancer AAC -0.027 0.6
mRNA Vorinostat gCSI pan-cancer AAC -0.0061 0.9
Download CSV